Search

everythinglearnresearchcommunity

for

Search:↓

Correct diagnosis is crucial for treating overlapping conditions like NMOSD and SLE effectively.

A woman with lupus had rare severe symptoms but improved with treatment.

A 16-year-old girl with lupus symptoms improved with treatment despite negative ANA tests.

The research found that Atypical Progeroid Syndrome has unique symptoms and is not caused by the buildup of a certain mutant protein.

There is no cure for myotonic dystrophy type 1, so treatment focuses on managing symptoms and complications.

Higher MIF levels in alopecia areata patients suggest it could be a treatment target and disease predictor.

The man was diagnosed with stage III multiple myeloma and treated to improve kidney function.

Infliximab improved skin and bowel symptoms in Crohn's disease but caused side effects and the disease returned after stopping treatment.

Markers help differentiate between apocrine and eccrine sweat glands to identify sweat gland tumors.

Dermoscopy and trichoscopy are useful for diagnosing skin signs in Dermatomyositis.

Abnormal T-cells from thymomas cause non-motor symptoms in some myasthenia gravis patients.

CD8+ T cells attack hair follicle stem cells, causing scarring and hair loss.

Managing multiple autoimmune diseases in one patient is very challenging.

Blocking the CXCR3 receptor reduces T cell accumulation in the skin and prevents hair loss in mice.

A humanized CXCL12 antibody may delay and treat alopecia areata by altering the immune response.

A rare endocrine disorder, APS 1, was diagnosed in a 26-year-old man in Bangladesh.

Recognizing the link between certain autoimmune disorders and neurological conditions can improve diagnosis and treatment.

Early stage bald spots are linked to skin inflammation and damage to the upper part of the hair follicle.

Men, diabetes, and high inflammation levels lead to higher COVID-19 antibodies.

Researchers found that certain miRNAs, which affect immune system regulation, are differently expressed in mice with a hair loss condition compared to healthy mice.

Nemolizumab improved both severe atopic dermatitis and alopecia areata in one patient.

Higher monocyte counts may predict poor response to adalimumab in hidradenitis suppurativa patients.

Accurate diagnosis is crucial for effectively treating severe alopecia and related symptoms.

Hair follicles and sweat glands show different keratin staining patterns.

Most patients with cutaneous dermatomyositis either improved or remained stable over 3.5 years.

Targeting MIG and MCP-1 may help treat inflammation in alopecia areata.

Different connective tissue disorders have unique symptoms and treatments, with varying outcomes and often require ongoing care from a specialist.

A new mutation in the mitochondrial DNA was found in a boy with MELAS, even though his family didn't show typical signs.

A man with hypoparathyroidism had other health issues that led to a diagnosis of a rare autoimmune disorder, APS-1.

JAK inhibitors may help treat alopecia areata by reversing hair loss.